New Research on Atopic Dermatitis from Dokkyo Medical University Summarized (Reduction in hospitalisations with dupilumab in Japanese adults with atopic dermatitis in a real-world setting)

MLA

“New Research on Atopic Dermatitis from Dokkyo Medical University Summarized (Reduction in Hospitalisations with Dupilumab in Japanese Adults with Atopic Dermatitis in a Real-World Setting).” Immunotherapy Weekly, 20 Sept. 2023, p. 3835. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.765604028&authtype=sso&custid=ns315887.

APA

New Research on Atopic Dermatitis from Dokkyo Medical University Summarized (Reduction in hospitalisations with dupilumab in Japanese adults with atopic dermatitis in a real-world setting). (2023, September 20). Immunotherapy Weekly, 3835.

Chicago

Immunotherapy Weekly. 2023. “New Research on Atopic Dermatitis from Dokkyo Medical University Summarized (Reduction in Hospitalisations with Dupilumab in Japanese Adults with Atopic Dermatitis in a Real-World Setting),” September 20. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.765604028&authtype=sso&custid=ns315887.